Procedural Codes/J7631

J7631 HCPCS 2026 Code: Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams

J7631 is the authoritative medical code for Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams. This classification is used in medical billing and clinical recording to specify the clinical criteria for cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams (HCPCS Level II J7631), ensuring healthcare documentation aligns with 2026 federal coding standards.

Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.

Official Registry Overview & Definition

Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams is a HCPCS Level II code J7631 for a Medicare-covered supply, service, or procedure. Short description: Cromolyn sodium noncomp unit.

Codes in This Family (40)

Official HCPCS Level II classifications in the same code family as J7631, with their registry titles.

  • J7601 — Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
  • J7604 — Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
  • J7605 — Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
  • J7606 — Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
  • J7607 — Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
  • J7608 — Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
  • J7609 — Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
  • J7610 — Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
  • J7611 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
  • J7612 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
  • J7613 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
  • J7614 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
  • J7615 — Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
  • J7620 — Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
  • J7622 — Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7624 — Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7626 — Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
  • J7627 — Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
  • J7628 — Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7629 — Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7632 — Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
  • J7633 — Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
  • J7634 — Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
  • J7635 — Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7636 — Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7637 — Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7638 — Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7639 — Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
  • J7640 — Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
  • J7641 — Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
  • J7642 — Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7643 — Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7644 — Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
  • J7645 — Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7647 — Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7648 — Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
  • J7649 — Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
  • J7650 — Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7657 — Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7658 — Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram

Related Codes & Numerical Sequence (Crawl Map)

Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures:

HCPCS Code J7626 Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
HCPCS Code J7627 Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
HCPCS Code J7628 Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
HCPCS Code J7629 Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
HCPCS Code J7630 Drugs Administered Other than Oral Method
HCPCS Code J7632 Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
HCPCS Code J7633 Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
HCPCS Code J7634 Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
HCPCS Code J7635 Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
HCPCS Code J7636 Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
MedCoder.aiClinical Desktop